Ez Char
Activated Charcoal
Padagis Us Llc
Human Otc Drug
NDC 0574-0122Ez Char also known as Activated Charcoal is a human otc drug labeled by 'Padagis Us Llc'. National Drug Code (NDC) number for Ez Char is 0574-0122. This drug is available in dosage form of Pellet. The names of the active, medicinal ingredients in Ez Char drug includes Activated Charcoal - 25 g/25g . The currest status of Ez Char drug is Active.
Drug Information:
| Drug NDC: | 0574-0122 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Ez Char |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Activated Charcoal |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Padagis Us Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Pellet |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | ACTIVATED CHARCOAL - 25 g/25g
|
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | ORAL
|
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | OTC MONOGRAPH NOT FINAL |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 14 Jan, 2002 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 26 Dec, 2025 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Application Number: | part357 |
| This corresponds to the NDA, ANDA, or BLA number reported by the labeler for products which have the corresponding Marketing Category designated. If the designated Marketing Category is OTC Monograph Final or OTC Monograph Not Final, then the Application number will be the CFR citation corresponding to the appropriate Monograph (e.g. “part 341”). For unapproved drugs, this field will be null. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Padagis US LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| RxCUI: | 309150
|
| The RxNorm Concept Unique Identifier. RxCUI is a unique number that describes a semantic concept about the drug product, including its ingredients, strength, and dose forms. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | 2P3VWU3H10
|
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 0574-0122-25 | 25 g in 1 BOTTLE (0574-0122-25) | 14 Jan, 2002 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose poison adsorbent
Product Elements:
Ez char activated charcoal activated charcoal activated charcoal bentonite
Indications and Usage:
Use for emergency use to adsorb swallowed poisons
Warnings:
Warnings ⢠do not give activated charcoal until after the patient has vomited unless directed by health professional ⢠do not use in persons who are not fully conscious ⢠do not use this product, unless directed by health professional, if turpentine, corrosives, such as alkalies (lye) and strong acids, or petroleum distillates, such as kerosene, gasoline, paint thinner, cleaning fluid or furniture polish, have been ingested ⢠tamper evident: do not use if protective seal is broken or missing
Dosage and Administration:
Directions remove seal. reconstitute into an oral suspension by adding 4 oz. of water to bottle, replacing cap and shaking well, or by pouring contents into a separate container, adding 4 oz. water, and stirring thoroughly. use immediately, do not store reconstituted product. 6 to 12 lb 1 to 2 tbs of reconstituted liquid 12 to 24 lb 2 to 4 tbs of reconstituted liquid 24 to 48 lb 4 to 8 tbs of reconstituted liquid 48 lb + entire amount of reconstituted liquid repeat dose immediately, if necessary.
Package Label Principal Display Panel:
Package/label principal display panel ez char® activated charcoal pellets poison adsorbent read label warnings and directions upon buying this product. for help using this product call a poison control center, emergency medical facility, or health professional. if help cannot be reached quickly, follow the directions on the label. in case of poisoning call your poison control center at 1-800-222-1222. net weight 0.88 oz (25 grams) label-rev05-19
Further Questions:
Questions? 1-800-328-5113 serious side effects associated with use of this product may be reported to this number.